SMTL ID : 3rts.1

Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.81 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.113, H.117, H.123 Ligands: KLG.6 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.113, A:H.117, A:H.123 ZN.2: 4 residues within 4Å: Chain A: H.63, D.65, H.78, H.91 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.63, A:D.65, A:H.78, A:H.91

3 x CA: CALCIUM ION(Non-covalent)

CA.3: 6 residues within 4Å: Chain A: A.52, D.53, G.85, I.86, G.87, D.89 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.53, A:G.85, A:G.87, A:D.89, H2O.1 CA.4: 3 residues within 4Å: Chain A: D.19, E.94, E.96 5 PLIP interactions: 3 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:D.19, A:E.94, A:E.94, H2O.1, H2O.2 CA.5: 6 residues within 4Å: Chain A: D.70, G.71, G.73, I.75, D.93, E.96 6 PLIP interactions: 6 interactions with chain A Metal complexes: A:D.70, A:G.71, A:G.73, A:I.75, A:D.93, A:E.96

1 x KLG: N-hydroxy-N~2~-[(2-phenylethyl)sulfonyl]glycinamide(Non-covalent)

KLG.6: 17 residues within 4Å: Chain A: G.74, I.75, L.76, A.77, H.78, L.109, T.110, H.113, E.114, H.117, H.123, V.130, F.132, P.133, T.134, Y.135 Ligands: ZN.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.76, A:T.110, A:H.113, A:Y.135, A:Y.135 Hydrogen bonds: A:L.76, A:A.77, A:A.77 pi-Stacking: A:H.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mordini, A. et al., Contribution of ligand free energy of solvation to design new potent MMPs inhibitors. J.Med.Chem. (2012)

Release Date

2012-07-04

Peptides

Macrophage metalloelastase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Macrophage metalloelastase

Related Entries With Identical Sequence